The founder of a US start-up that promised to revolutionise blood testing has agreed to settle charges that she raised over $700m (£500m) fraudulently. The Securities and Exchange Commission, a top US financial regulator, said Elizabeth Holmes and Theranos deceived investors about the firm"s technology. Ms Holmes will lose control of the firm and be fined $500,000.
No comments:
Post a Comment